Cargando…
Mn(II) Quinoline Complex (4QMn) Restores Proteostasis and Reduces Toxicity in Experimental Models of Huntington’s Disease
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder, of the so-called minority diseases, due to its low prevalence. It is caused by an abnormally long track of glutamines (polyQs) in mutant huntingtin (mHtt), which makes the protein toxic and prone to aggregation. Many path...
Autores principales: | Merino, Marián, Sequedo, María Dolores, Sánchez-Sánchez, Ana Virginia, Clares, Mª Paz, García-España, Enrique, Vázquez-Manrique, Rafael P., Mullor, José L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409211/ https://www.ncbi.nlm.nih.gov/pubmed/36012207 http://dx.doi.org/10.3390/ijms23168936 |
Ejemplares similares
-
Small Molecule Pytren-4QMn Metal Complex Slows down Huntington’s Disease Progression in Male zQ175 Transgenic Mice
por: Merino, Marián, et al.
Publicado: (2023) -
Metformin intake associates with better cognitive function in patients with Huntington's disease
por: Hervás, David, et al.
Publicado: (2017) -
Targeting the proteostasis network in Huntington’s disease
por: Soares, Tânia R., et al.
Publicado: (2019) -
Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease
por: Sanchis, Ana, et al.
Publicado: (2019) -
Significant In Vivo Anti-Inflammatory Activity of Pytren4Q-Mn a Superoxide Dismutase 2 (SOD2) Mimetic Scorpiand-Like Mn (II) Complex
por: Serena, Carolina, et al.
Publicado: (2015)